Technical Analysis for SRNE - Sorrento Therapeutics, Inc.

Grade Last Price % Change Price Change
D 8.58 6.06% 0.49
SRNE closed up 6.06 percent on Wednesday, July 28, 2021, on 59 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical SRNE trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Wide Bands Range Expansion 0.00%
NR7 Range Contraction 6.06%
Wide Bands Range Expansion 6.06%
Down 3 Days in a Row Weakness 6.06%
Down 4 Days in a Row Weakness 6.06%
50 DMA Resistance Bearish 3.87%
Wide Bands Range Expansion 3.87%
Down 3 Days in a Row Weakness 3.87%
Fell Below 200 DMA Bearish 3.13%
Older End-of-Day Signals for SRNE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakout about 13 hours ago
Rose Above 50 DMA about 14 hours ago
10 DMA Resistance about 18 hours ago
50 DMA Resistance about 18 hours ago
Up 5% about 18 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Sorrento Therapeutics, Inc. Description

Sorrento Therapeutics, Inc., a development stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel and proprietary biotherapeutics for the treatment of cancer, inflammation, metabolic, and infectious diseases in the United States. The company's G-MAB, a human antibody library platform, facilitates the rapid identification and isolation of highly specific antibody therapeutic product candidates that bind to disease targets appropriate for antibody therapy. Its human antibody library technology is used to construct large human antibody libraries. It has license agreement with OPKO Health, Inc. to develop, manufacture, use, market, sell, offer to sell, import, and export certain products related to the development, manufacture, marketing, and sale of drugs for ophthalmological indications. Sorrento Therapeutics, Inc. is based in San Diego, California.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Biopharmaceutical Cancer Biology Immunology Immune System Infectious Diseases Disease Treatment Of Cancer Monoclonal Antibody Inflammation Antibody Therapeutic Product Library Opko Health Antibody Therapy

Is SRNE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 19.39
52 Week Low 5.17
Average Volume 7,110,972
200-Day Moving Average 8.74
50-Day Moving Average 8.51
20-Day Moving Average 8.68
10-Day Moving Average 8.34
Average True Range 0.58
ADX 15.64
+DI 25.31
-DI 23.78
Chandelier Exit (Long, 3 ATRs) 9.34
Chandelier Exit (Short, 3 ATRs) 9.42
Upper Bollinger Bands 10.21
Lower Bollinger Band 7.16
Percent B (%b) 0.47
BandWidth 35.10
MACD Line -0.11
MACD Signal Line -0.08
MACD Histogram -0.0336
Fundamentals Value
Market Cap 2.26 Billion
Num Shares 263 Million
EPS -2.40
Price-to-Earnings (P/E) Ratio -3.57
Price-to-Sales 40.11
Price-to-Book 10.20
PEG Ratio -0.07
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.41
Resistance 3 (R3) 9.33 8.97 9.27
Resistance 2 (R2) 8.97 8.76 9.01 9.22
Resistance 1 (R1) 8.78 8.63 8.88 8.86 9.18
Pivot Point 8.42 8.42 8.47 8.46 8.42
Support 1 (S1) 8.23 8.21 8.32 8.30 7.98
Support 2 (S2) 7.87 8.08 7.91 7.94
Support 3 (S3) 7.67 7.87 7.89
Support 4 (S4) 7.75